Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine and Bupivacaine in Cesarean Section
NCT05469529Unknown
- Sponsor
- KRL Hospital
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in cesarean section (2 arms), sponsored by KRL Hospital. Primary endpoints: Onset of Sensory Block, Onset of Motor Block and 2 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
cesarean section
Beyond the preview
Go deeper on NCT05469529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05469529.